Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Session IX: Chronic Lymphocytic Leukemia
13:46

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CLL State of the Art Update: Biology, Therapeutic Landscape, Infections, Second Malignancies, & Resistance

FEATURING Florencia Cymbalista
  • 368 views
  • October 25, 2018
  • 2
16:37

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Evolving Firstline Treatment for Patients with CLL

FEATURING Nitin Jain
  • 367 views
  • October 25, 2018
  • 2
15:20

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

DEBATE: The Chemoimmunotherapy Era in CLL is Over

FEATURING Philip Thompson
  • 235 views
  • October 25, 2018
  • 1
14:11

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

DEBATE: Chemoimmunotherapy in CLL is Over? No

FEATURING Barbara Eichhorst
  • 240 views
  • October 25, 2018
  • 1
15:46

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Optimal Sequencing of Molecules in the Treatment in Chronic Lymphocytic Leukemia

FEATURING Anthony R. Mato
  • 1,165 views
  • October 25, 2018
  • 6
07:53

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Risk of Infection with Ibrutinib in Patients with CLL: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials Oral Abstract CLL 116

FEATURING Somedeb Ball
  • 376 views
  • November 5, 2018
  • 1
10:13

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CLL Next Generation Reversible BTK Inhibitor, For Overcoming Acquired Resistance to Irreversible BTK Inhibitors

FEATURING Barbara Brandhuber
  • 278 views
  • November 5, 2018
13:08

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

CLL Next Questions: Biology, MRD, Risk Stratification, New Molecules, Subsequent Lines & CAR T-cells

FEATURING Florencia Cymbalista
  • 420 views
  • October 25, 2018
  • 1